@Larvol99
Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus
Nothing here yet.
Nothing here yet.
Sep 27, 2024 · 2 min read · Background: In the phase 3 HERO study, the oral GnRH receptor antagonist, relugolix, demonstrated suppression of testosterone to castrate levels in 96.7% of patients, which was superior to leuprolide, and a 54% lower risk of major adverse cardiovascu...
Join discussionSep 27, 2024 · 2 min read · Methods:We enrolled an age- (30–49, 50–69, 70–89 years) and sex-stratified sample of 18 patients (PTs) who underwent a physical examination at 2 urban hospitals by each of 12 primary care MDs. We assigned screening guideline formatting (color-coding ...
Join discussionSep 27, 2024 · 2 min read · Background:A phase I/II clinical trial in advanced hepatocellular carcinoma (HCC) conducted by Yakult Honsha (NCT02400788) indicated the combination of the HDAC inhibitor resminostat and sorafenib was beneficial compared to sorafenib for patients wit...
Join discussionSep 27, 2024 · 2 min read · Background:In 2L+ aGEC, taxanes +/- ramucirumab or IRI are recommended treatment options. IRI has been tested in multiple single arm and randomized trials in second line (2L)+ aGEC, with reported objective response rates (ORR) in the 15–29% range and...
Join discussionSep 27, 2024 · 1 min read · Age range 14–70 years old; ECOG performance status 0–2; Estimated survival time > 3 months Histological confirmed Peripheral T cell lymphoma None of chemotherapy or radiotherapy has been previously used None of chemotherapy contraindication: hemoglob...
Join discussion